Clinical Trial Update: Trachoma Elimination Study by Focused Antibiotic (TESFA) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating a focused antibiotic for Trachoma (TESFA) has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Trachoma

Snippet

Sponsor: Emory University | Conditions: Trachoma | Phase 4 | Status: WITHDRAWN